Abbott Laboratories Stock Surges 11% as Company Lifts Full Year Profit Guidance
Abbott Laboratories stock surged 11% after raising full-year EPS guidance and beating Q2 expectations across segments.
Read the full articleAbbott Laboratories stock surged 11% after raising full-year EPS guidance and beating Q2 expectations across segments.
Read the full article
Comments
Sign in to join the conversation.
No comments yet. Be the first.